
Posted: January 30, 2020 by quartzdev
Biosimilar Coverage Update
In spring 2019, an article about biosimilars appeared in our provider newsletter. In case you missed it or would like a refresher, download Biosimilars vs. Generics
Note: starting June 1, 2020, Quartz will no longer be covering the brand or innovator product when a biosimilar is available. However, you do not have to wait to order or prescribe a biosimilar — you can start now. Some of the biosimilars will still require prior authorization, similar to the current criteria for the innovator product.
RELATED POSTS
Quartz Launches Mental Well-Being Programs with AbleTo
Read more
Quartz Continues Partnership with Milwaukee Brewers for 2023 Season
Read more
Welcome to better well-being
Read more
Quartz Receives Richard L. Doyle Award for Successful Prior Authorization Automation
Read more
Updates to claims edit software system
Read more